Blog
RSS FeedPosted by Michael Wonder on 05 Feb 2016
PHARMAC decision relating to filgrastim and methotrexate pre-filled syringes
5 February 2016 - PHARMAC is pleased to announce the approval of an agreement with Novartis New Zealand Ltd. involving filgrastim, ...
Posted by Michael Wonder on 05 Feb 2016
Cancer Drugs Fund 'should be managed better', say MPs
5 February 2016 - A special NHS fund for cancer medicines in England needs to be managed more effectively, says a ...
Posted by Michael Wonder on 03 Feb 2016
CADTH calls for patient input on a new submission from Janssen-Cilag for canagliflozin hemihydrate with metformin hydrochloride
3 February 2016 - CADTH has received notice of a pending submission from Janssen-Cilag for canagliflozin hemihydrate with metformin hydrochloride for ...
Posted by Michael Wonder on 03 Feb 2016
Request for proposals - influenza vaccine
3 February 2016 - PHARMAC invites proposals for the supply of seasonal influenza vaccine in New Zealand. ...
Posted by Michael Wonder on 03 Feb 2016
PHARMAC decision to widen access to budesonide with eformoterol (Symbicort Turbuhaler and Vannair)
3 February 2016 - From 1 March 2016, the effect of the decision is that: ...
Posted by Michael Wonder on 03 Feb 2016
PHARMAC decision relating to a number of respiratory products
3 February 2016 - PHARMAC is pleased to announce the approval of agreements with Boehringer Ingleheim and GlaxoSmithKline involving a number ...
Posted by Michael Wonder on 03 Feb 2016
2016 April price disclosure cycle - indicative prices
3 February 2016 - Indicative 1 April 2016 prices resulting from the 2016 April cycle of price disclosure have now been ...
Posted by Michael Wonder on 02 Feb 2016
Review of NHS drugs assessment ordered
31 January 2016 - An independent review is to be carried out of the way drugs are assessed for use on ...
Posted by Michael Wonder on 01 Feb 2016
CADTH calls for patient input on a new submission from Genzyme for Cerdelga
1 February 2016 - CADTH has received notice of a pending submission from Genzyme for Cerdelga (eliglustat tartrate) for the treatment ...
Posted by Michael Wonder on 01 Feb 2016
Dad pushing for a subsidy on EpiPens
30 January 2016 - A Whanganui father wants EpiPens to be funded by PHARMAC. ...
Posted by Michael Wonder on 31 Jan 2016
New Zealand Pharmaceutical Schedule - 1 February 2016 update
1 February 2016 - The second issue of the Schedule for 2016 sees the listing of two new medicines: dimethyl ...
Posted by Michael Wonder on 31 Jan 2016
Schedule of Pharmaceutical Benefits - 1 February 2016 update
1 February 2016 - The February 2016 issue of the Schedule sees the listing of one new medicine (ruxolitinib phosphate) ...
Posted by Michael Wonder on 30 Jan 2016
CADTH calls for patient input on a new submission from Celgene for Otezla
29 January 2016 - CADTH has received notice of a pending resubmission from Celgene for Otezla (apremilast) for use by patients ...
Posted by Michael Wonder on 29 Jan 2016
Agenda for the 3 February 2016 TC meeting
29 January 2016 - The Transparency Commission will consider the reimbursement of sufentanil (Zalviso), efmoroctocog alfa (Elocto) and asfotase alfa (Stensiq). ...
Posted by Michael Wonder on 29 Jan 2016
PBS biosimilar awareness - updated implementation framework
29 January 2016 - As part of the PBS biosimilar awareness Initiative, the updated implementation framework is now available. ...